Skip to content

Clinical trials

Observational Metabolic Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Observational Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20071
20091
20104
20112
20121
20131
20141
20153
20172
20182
20201
20221
20234
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting8
Unknown status8
Active, not recruiting3
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Central South University2
Dong Peng2
Guang'anmen Hospital of China Academy of Chinese Medical Sciences2
Guangdong Provincial People's Hospital2
Ruijin Hospital2
Beijing Jishuitan Hospital1
China-Japan Friendship Hospital1
Chinese PLA General Hospital1
First Affiliated Hospital of Chongqing Medical University1
Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome36
Obesity15
Cardiovascular Diseases8
Diabetes Mellitus, Type 27
Diabetes Mellitus6
Hypertension5
Renal Insufficiency, Chronic5
Coronary Artery Disease4
Fatty Liver3
Overweight3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.